Join the Voltaren group to help and get support from people like you.
Voltaren News
FDA Medwatch Alert: FDA Warns Consumers Not to Purchase or Use Artri and Ortiga Products, Which May Contain Hidden Drug Ingredients
April 20, 2021 --FDA is warning consumers not to purchase or use products marketed with variations of the names “Artri” or “Ortiga” due to potentially dangerous hidden active drug ingredients not list...
FDA Medwatch Alert: Drug Safety Communication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later
ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding...
FDA Medwatch Alert: Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke
[Posted 07/09/2015] ISSUE: FDA is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on ...
FDA Medwatch Alert: Super Arthgold by Nano Well-being Health: Recall - Undeclared Drug Ingredients
ISSUE: Nano Well-being Health Inc. issued a voluntary recall of Super Arthgold, 500 mg capsules to the consumer level. FDA laboratory analysis has found the product to contain chlorzoxazone,...
FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient
Reumofan Plus USA, LLC and Reumofan USA, LLC is recalling "Reumofan Plus" Tablets, Lot# 99515, exp. 09/16, because they contain undeclared active pharmaceutical ingredients: methocarbamol,...
FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.” The pr...
FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient
[UPDATED 08/21/2012] FDA is issuing an updated alert that Reumofan Plus and Reumofan Plus Premium contain undeclared active ingredients found in prescription drugs that should be used only under the...
FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient
ISSUE: FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Back Pain, Ankylosing Spondylitis, Frozen Shoulder, Aseptic Necrosis, Muscle Pain, Osteoarthritis, Pain, Period Pain, Dysmenorrhea, Rheumatoid Arthritis, Sciatica